BOSTON, Feb. 21, 2019 /PRNewswire/ -- VRHealth, the healthcare technology company providing specialized virtual reality (VR) technology solutions and data analysis, today announced the results of a clinical study of breast cancer patients who suffer from hot flashes and night sweats, showing a 50 percent decrease in those debilitating events after subjects used the VRHealth virtual reality (VR) coaching environment. Among other positive outcomes, study participants reported significant improvements in their sleep quality and fewer disruptions to their daily lives following a three-week experiment with the VR solution.
The clinical study evaluated the efficacy of the AI-VR therapist, which offers a psychological intervention based on cognitive behavioral therapy and mindfulness-based stress reduction. Breast cancer patients and survivors frequently experience hot flashes and night sweats as a result of chemotherapy or endocrine therapy, which cause changes to hormonal levels. Often distressing and embarrassing, hot flashes interfere with daily life, while night sweats lead to difficulty sleeping and subsequent fatigue—side effects disturbing enough to hinder compliance with anticancer therapies.
The study collected and analyzed demographic, clinical, physiological, and patient-reported outcome data during a ten-month period in 2018. Study participants wore VR goggles every day for 24 days in order to experience the virtual reality of a completely immersive, 360-degree snowy winter scene, dubbed Frosty. They were surveyed before and after the AI-VR intervention to assess their physical and psychological symptoms related to stress, sleep quality, and quality of life.
The findings indicate that after daily exposure to the cold-looking AI-VR virtual wintertime world, the breast cancer patients reported 50 percent fewer hot flashes and night sweats. They also found that occurrences were less intense, the psychological distress related to health concerns was diminished, and the level of interference with their daily activities was lowered.
"This clinical research report shows that we've developed a highly effective solution for the hot flashes that plague breast cancer patients and survivors, to the extent of improving their overall quality of life," says VRHealth CEO Eran Orr. "The results validate our protocol for alleviating difficult symptoms with a virtual reality intervention that is therapy-based, non-pharmaceutical, and easy to use."
VRHealth's solutions utilize artificial intelligence (AI) and cloud-computing algorithms to deliver advanced data analytics. Utilizing sophisticated tracking tools, VRHealth provides data analysis, as the patient is engaged in the VR therapy, so that doctors and clinicians can personalize and customize healthcare solutions for their patients.
VRHealth is a first-of-its-kind healthcare technology company that helps clinicians better manage their patients' care via specialized virtual reality (VR) technology solutions and data analysis. The VRHealth solution collects and examines user data through artificial intelligence (AI) and cloud-computing algorithms to deliver advanced data analytics in real-time, consistently enabling healthcare providers to enhance their users' and payers' healthcare experiences. The company offers a variety of patent-pending solutions from rehabilitation services to cognitive testing, from pain management to psychological assessment. VRHealth is one of the first VR healthcare companies in the world that is ISO-certified and all its medical applications are FDA Authorized. VRHealth works with several world-renowned U.S. healthcare providers, hospitals and rehabilitation centers. Founded in 2016, VRHealth is headquartered in Israel and Boston, Massachusetts. Learn more at www.xr.health/.
CONTACT: DeeDee Rudenstein, 267-521-9654, email@example.com